Henkel closes Cognis sale
This article was originally published in The Rose Sheet
Executive Summary
Consumer products manufacturer completed the sale of its Cognis chemical business in a transaction valued at $2.2 bil., the company announces Nov. 30. Henkel said it would sell its chemical business to focus on strengthening its existing consumer products and industrial services businesses (1"The Rose Sheet" Nov. 19, p. 11). Cognis was purchased by a consortium of investors led by Permira...
You may also be interested in...
Cognis Acquisition Would Reinforce BASF's Personal-Care Portfolio
Already one of the world's largest chemical companies, BASF is reportedly close to a deal to acquire fellow German supplier Cognis
Henkel North American Cosmetics Business Restructuring Planned
Henkel's North American cosmetics and toiletries business will undergo a restructuring aimed at substantial cost reductions, the company noted in a Nov. 12 presentation to analysts. The business includes California-based Schwarzkopf & Dep and the Canadian Schwarzkopf Professional salon supplier
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.